Delivery Order SPE2DR25D3020-SPE2DR26F9P9D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dapagliflozin 10 mg tablets (30-count) with a ceiling value of $14,660.88 under a firm fixed-price contract type. The award was made on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dapagliflozin 10 mg tablets in a quantity of 30-unit packages, with a ceiling value of $5,581.69. This contract, awarded on August 7, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and carries no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dapagliflozin 10 mg tablets (30-count packaging) with a contract value of $46,041.24. This competitively awarded, non-set-aside delivery order was issued on September 15, 2025, with an ultimate completion date of September 16, 2025, and employs firm fixed-price terms. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dapagliflozin 10 mg tablets in a 30-count package, with a ceiling value of $1,376.58. This competitively awarded, firm fixed-price contract was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The delivery order carries no set-aside designation, indicating it was competed among all eligible vendors. AmerisourceBergen Drug Corp will perform this work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count packages) valued at $8,351.36 under a firm fixed price contract. The award was made on December 10, 2025, with an ultimate completion date of December 11, 2025, and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded contract reflecting the agency's open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 tablets, valued at $1,540.36. This is a firm fixed-price delivery order with an ultimate completion date of November 17, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dapagliflozin 10 mg tablets (30-count units) with a ceiling value of $1,734.22. The contract, awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, utilizes firm fixed pricing and was not set aside for small business or other designated categories. This delivery order represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This competitive award, valued at approximately $45K, represents a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a contract ceiling value of $1,949.87. This firm fixed-price delivery order, with an ultimate completion date of October 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $6,100.21 and an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting the federal government's pharmaceutical supply requirements. The order was placed to the company's place of performance in...
- SPE2DR25D3020Indefinite Delivery Contract
- SPE2DR25D3020-SPE2DR26F9P9DDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for dapagliflozin 10 mg tablets (30-count) valued at $21,014.21. This firm fixed price delivery order, awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a non-competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999.99 million through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a broad portfolio of medications and medical products to defense and civilian healthcare systems. The company's contract awards with the DLA span diverse therapeutic categories including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialty medical supplies. The dapagliflozin delivery order reflects routine pharmaceutical procurement needs within the Defense Health Agency supply chain, supporting military medical operations with essential diabetes management medications. As a child contract under the SPE2DX prime IDC, this award demonstrates AmerisourceBergen's ongoing role as a primary pharmaceutical supplier for federal military healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.0k | 12/10/25 |